Adient (ADNT) Misses Q3 EPS by 3c; raises guidance

Go back to Adient (ADNT) Misses Q3 EPS by 3c; raises guidance

Adient (ADNT) PT Raised to $26 at UBS

August 7, 2025 5:56 AM EDT

UBS analyst Joseph Spak raised the price target on Adient (NYSE: ADNT) to $26.00 (from $25.00) while maintaining a Neutral rating.

The analyst comments "Net: ADNT investment thesis looks a bit stronger given 1) continued solid business performance, 2) beneficiary from US re-shoring, 3) path to normalized... More